An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells

Haishuang Lin, Qiang Li, Yuguo Lei

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Human induced pluripotent stem cells (iPSCs) are ideal cell sources for personalized cell therapies since they can be expanded to generate large numbers of cells and differentiated into presumably all the cell types of the human body in vitro. In addition, patient specific iPSC-derived cells induce minimal or no immune response in vivo. However, with current cell culture technologies and bioprocessing, the cost for biomanufacturing clinical-grade patient specific iPSCs and their derivatives are very high and not affordable for majority of patients. In this paper, we explored the use of closed and miniature cell culture device for biomanufacturing patient specific neural stem cells (NSCs) from iPSCs. We demonstrated that, with the assist of a thermoreversible hydrogel scaffold, the bioprocessing including iPSC expansion, iPSC differentiation into NSCs, the subsequent depletion of undifferentiated iPSCs from the NSCs, and concentrating and transporting the purified NSCs to the surgery room, could be integrated and completed within two closed 15 ml conical tubes.

Original languageEnglish (US)
Title of host publicationFood, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting
PublisherAIChE
Pages918-930
Number of pages13
ISBN (Electronic)9781510858022
DOIs
StatePublished - Jan 1 2017
EventFood, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting - Minneapolis, United States
Duration: Oct 29 2017Nov 3 2017

Publication series

NameFood, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting
Volume2

Other

OtherFood, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting
CountryUnited States
CityMinneapolis
Period10/29/1711/3/17

Fingerprint

bioprocessing
Induced Pluripotent Stem Cells
Neural Stem Cells
Stem cells
stem cells
Cell Differentiation
cells
cell culture
Cell Culture Techniques
Cell culture
Hydrogel
hydrocolloids
concentrating
Cell- and Tissue-Based Therapy
induced pluripotent stem cells
Human Body
cell differentiation
surgery
Cell Count
chemical derivatives

ASJC Scopus subject areas

  • Chemical Engineering(all)
  • Food Science
  • Engineering(all)

Cite this

Lin, H., Li, Q., & Lei, Y. (2017). An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells. In Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting (pp. 918-930). (Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting; Vol. 2). AIChE. https://doi.org/10.1038/srep40191

An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells. / Lin, Haishuang; Li, Qiang; Lei, Yuguo.

Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting. AIChE, 2017. p. 918-930 (Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting; Vol. 2).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Lin, H, Li, Q & Lei, Y 2017, An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells. in Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting. Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting, vol. 2, AIChE, pp. 918-930, Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting, Minneapolis, United States, 10/29/17. https://doi.org/10.1038/srep40191
Lin H, Li Q, Lei Y. An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells. In Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting. AIChE. 2017. p. 918-930. (Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting). https://doi.org/10.1038/srep40191
Lin, Haishuang ; Li, Qiang ; Lei, Yuguo. / An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells. Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting. AIChE, 2017. pp. 918-930 (Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting).
@inproceedings{6a07c6ea9a2a43babb73197e2f06eba7,
title = "An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells",
abstract = "Human induced pluripotent stem cells (iPSCs) are ideal cell sources for personalized cell therapies since they can be expanded to generate large numbers of cells and differentiated into presumably all the cell types of the human body in vitro. In addition, patient specific iPSC-derived cells induce minimal or no immune response in vivo. However, with current cell culture technologies and bioprocessing, the cost for biomanufacturing clinical-grade patient specific iPSCs and their derivatives are very high and not affordable for majority of patients. In this paper, we explored the use of closed and miniature cell culture device for biomanufacturing patient specific neural stem cells (NSCs) from iPSCs. We demonstrated that, with the assist of a thermoreversible hydrogel scaffold, the bioprocessing including iPSC expansion, iPSC differentiation into NSCs, the subsequent depletion of undifferentiated iPSCs from the NSCs, and concentrating and transporting the purified NSCs to the surgery room, could be integrated and completed within two closed 15 ml conical tubes.",
author = "Haishuang Lin and Qiang Li and Yuguo Lei",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/srep40191",
language = "English (US)",
series = "Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting",
publisher = "AIChE",
pages = "918--930",
booktitle = "Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting",

}

TY - GEN

T1 - An integrated miniature bioprocessing for personalized human induced pluripotent stem cell expansion and differentiation into neural stem cells

AU - Lin, Haishuang

AU - Li, Qiang

AU - Lei, Yuguo

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Human induced pluripotent stem cells (iPSCs) are ideal cell sources for personalized cell therapies since they can be expanded to generate large numbers of cells and differentiated into presumably all the cell types of the human body in vitro. In addition, patient specific iPSC-derived cells induce minimal or no immune response in vivo. However, with current cell culture technologies and bioprocessing, the cost for biomanufacturing clinical-grade patient specific iPSCs and their derivatives are very high and not affordable for majority of patients. In this paper, we explored the use of closed and miniature cell culture device for biomanufacturing patient specific neural stem cells (NSCs) from iPSCs. We demonstrated that, with the assist of a thermoreversible hydrogel scaffold, the bioprocessing including iPSC expansion, iPSC differentiation into NSCs, the subsequent depletion of undifferentiated iPSCs from the NSCs, and concentrating and transporting the purified NSCs to the surgery room, could be integrated and completed within two closed 15 ml conical tubes.

AB - Human induced pluripotent stem cells (iPSCs) are ideal cell sources for personalized cell therapies since they can be expanded to generate large numbers of cells and differentiated into presumably all the cell types of the human body in vitro. In addition, patient specific iPSC-derived cells induce minimal or no immune response in vivo. However, with current cell culture technologies and bioprocessing, the cost for biomanufacturing clinical-grade patient specific iPSCs and their derivatives are very high and not affordable for majority of patients. In this paper, we explored the use of closed and miniature cell culture device for biomanufacturing patient specific neural stem cells (NSCs) from iPSCs. We demonstrated that, with the assist of a thermoreversible hydrogel scaffold, the bioprocessing including iPSC expansion, iPSC differentiation into NSCs, the subsequent depletion of undifferentiated iPSCs from the NSCs, and concentrating and transporting the purified NSCs to the surgery room, could be integrated and completed within two closed 15 ml conical tubes.

UR - http://www.scopus.com/inward/record.url?scp=85048553556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048553556&partnerID=8YFLogxK

U2 - 10.1038/srep40191

DO - 10.1038/srep40191

M3 - Conference contribution

C2 - 28057917

AN - SCOPUS:85048553556

T3 - Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting

SP - 918

EP - 930

BT - Food, Pharmaceutical and Bioengineering Division 2017 - Core Programming Area at the 2017 AIChE Annual Meeting

PB - AIChE

ER -